Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Objective: We aimed to evaluate the efficacy of canagliflozin for the treatment of specific cardiovascular and renal outcomes in Type 2 diabetes mellitus (T2DM) patients by means of a systematic review and meta-analysis.Methods: We performed comprehensive searches of PubMed, the Cochrane Library, an...

Full description

Bibliographic Details
Main Authors: Lei Tian, Yuzi Cai, Huijuan Zheng, Sinan Ai, Mengqi Zhou, Qian Luo, Jingyi Tang, Weijing Liu, Yaoxian Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
canagliflozin
Type 2 diabetes mellitus
Cardiovascular outcomes
renal function
renal events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.691878/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.691878/full

Similar Items